Symbols / GDRX $2.07 +0.98% GoodRx Holdings, Inc.

Healthcare • Health Information Services • United States • NMS
GDRX Chart
About

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Health Information Servi Market Cap 709.13M
Enterprise Value 983.26M Income 30.44M Sales 796.85M
Book/sh 1.81 Cash/sh 0.76 Dividend Yield —
Payout 0.00% Employees 697 IPO —
P/E 23.00 Forward P/E 5.63 PEG —
P/S 0.89 P/B 1.15 P/C —
EV/EBITDA 8.04 EV/Sales 1.23 Quick Ratio 2.10
Current Ratio 2.61 Debt/Eq 88.08 LT Debt/Eq —
EPS (ttm) 0.09 EPS next Y 0.37 EPS Growth -9.70%
Revenue Growth -1.90% Earnings 2026-05-06 ROA 4.75%
ROE 4.54% ROIC — Gross Margin 92.77%
Oper. Margin 18.98% Profit Margin 3.82% Shs Outstand 108.61M
Shs Float 95.50M Short Float 9.46% Short Ratio 2.39
Short Interest — 52W High 5.81 52W Low 1.77
Beta 1.47 Avg Volume 3.04M Volume 884.45K
Target Price $2.82 Recom Hold Prev Close $2.05
Price $2.07 Change 0.98%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$2.82
Mean price target
2. Current target
$2.07
Latest analyst target
3. DCF / Fair value
$13.58
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.07
Low
$1.90
High
$3.50
Mean
$2.82

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-04 main Wells Fargo Overweight → Overweight $4
2026-03-03 main Citigroup Buy → Buy $4
2026-03-02 main Goldman Sachs Neutral → Neutral $3
2026-02-27 main Mizuho Neutral → Neutral $3
2026-02-27 down JP Morgan Overweight → Neutral —
2026-01-22 down Jefferies Buy → Hold $3
2026-01-09 main Citigroup Buy → Buy $5
2025-12-18 main Morgan Stanley Equal-Weight → Equal-Weight $4
2025-12-09 init Barclays — → Underweight $3
2025-11-11 main JP Morgan Overweight → Overweight $5
2025-11-10 main TD Cowen Buy → Buy $6
2025-11-06 main UBS Neutral → Neutral $4
2025-11-06 main Mizuho Neutral → Neutral $4
2025-08-11 main UBS Neutral → Neutral $4
2025-05-13 main UBS Neutral → Neutral $5
2025-05-09 main Goldman Sachs Neutral → Neutral $5
2025-04-29 main Wells Fargo Overweight → Overweight $7
2025-04-10 main Truist Securities Hold → Hold $6
2025-02-28 main Wells Fargo Overweight → Overweight $8
2025-01-10 main Citigroup Buy → Buy $6
News
RSS: Latest GDRX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-12 REY-GIRAUD AGNES Director — 192,185 $0.47 $90,327
2026-03-12 REY-GIRAUD AGNES Director — 75,219 $0.00 $0
2026-03-06 NABIEY ROMIN Officer — 12,434 — —
2026-02-13 MCGINNIS CHRISTOPHER ALAN Officer — 179,120 — —
2026-02-13 NABIEY ROMIN Officer — 4,804 — —
2026-02-06 NABIEY ROMIN Officer — 12,663 — —
2026-01-21 WAGNER SCOTT W. Director — 31,394 — —
2026-01-15 BARNES WENDY LYNN Officer and Director — 665,302 — —
2025-12-31 BRUEHLMAN RONALD E Director — 18,251 $0.00 $0
2025-12-31 HIRSCH DOUGLAS JOSEPH Director — 10,950 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
796.85
+0.57%
792.32
+5.61%
750.26
-2.12%
766.55
Operating Revenue
779.17
+1.02%
771.32
+5.63%
730.21
-2.13%
746.13
Cost Of Revenue
57.60
+19.46%
48.22
-27.96%
66.92
+2.84%
65.08
Reconciled Cost Of Revenue
57.60
+19.46%
48.22
-27.96%
66.92
+2.84%
65.08
Gross Profit
739.26
-0.65%
744.11
+8.89%
683.34
-2.59%
701.48
Operating Expense
651.76
-3.91%
678.26
-4.52%
710.35
+1.52%
699.74
Research And Development
121.03
-2.20%
123.75
-8.90%
135.84
-5.10%
143.14
Selling General And Administration
445.52
-8.14%
484.98
+3.88%
466.84
-7.08%
502.42
Selling And Marketing Expense
331.56
-9.68%
367.11
+7.55%
341.33
-4.56%
357.63
General And Administrative Expense
113.96
-3.31%
117.86
-6.10%
125.52
-13.31%
144.79
Other Gand A
113.96
-3.31%
117.86
-6.10%
125.52
-13.31%
144.79
Total Expenses
709.36
-2.36%
726.48
-6.53%
777.27
+1.63%
764.82
Operating Income
87.49
+32.87%
65.85
+343.81%
-27.01
-1653.91%
1.74
Total Operating Income As Reported
87.49
+32.87%
65.85
+343.81%
-27.01
-1653.91%
1.74
EBITDA
184.36
+19.78%
153.92
+41.44%
108.82
+66.94%
65.19
Normalized EBITDA
184.36
+18.18%
156.00
+43.35%
108.82
+66.94%
65.19
Reconciled Depreciation
85.22
+22.55%
69.54
-35.41%
107.67
+98.73%
54.18
EBIT
99.14
+17.49%
84.38
+7199.48%
1.16
-89.50%
11.01
Total Unusual Items
0.00
+100.00%
-2.08
0.00
0.00
Total Unusual Items Excluding Goodwill
0.00
+100.00%
-2.08
0.00
0.00
Special Income Charges
0.00
+100.00%
-2.08
0.00
0.00
Other Special Charges
—
2.08
—
—
Net Income
30.44
+85.72%
16.39
+284.82%
-8.87
+72.99%
-32.83
Pretax Income
56.54
+79.71%
31.46
+156.61%
-55.57
-139.21%
-23.23
Net Non Operating Interest Income Expense
-31.67
-6.82%
-29.65
-20.74%
-24.56
+1.65%
-24.97
Interest Expense Non Operating
42.60
-19.49%
52.92
-6.71%
56.73
+65.66%
34.24
Net Interest Income
-31.67
-6.82%
-29.65
-20.74%
-24.56
+1.65%
-24.97
Interest Expense
42.60
-19.49%
52.92
-6.71%
56.73
+65.66%
34.24
Interest Income Non Operating
10.93
-53.02%
23.27
-27.66%
32.17
+246.89%
9.27
Interest Income
10.93
-53.02%
23.27
-27.66%
32.17
+246.89%
9.27
Other Income Expense
0.72
+115.16%
-4.74
-18.19%
-4.01
—
Other Non Operating Income Expenses
0.72
+126.99%
-2.66
+33.63%
-4.01
—
Tax Provision
26.10
+73.19%
15.07
+132.27%
-46.70
-586.65%
9.60
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
+100.00%
-0.44
0.00
0.00
Net Income Including Noncontrolling Interests
30.44
+85.72%
16.39
+284.82%
-8.87
+72.99%
-32.83
Net Income From Continuing Operation Net Minority Interest
30.44
+85.72%
16.39
+284.82%
-8.87
+72.99%
-32.83
Net Income From Continuing And Discontinued Operation
30.44
+85.72%
16.39
+284.82%
-8.87
+72.99%
-32.83
Net Income Continuous Operations
30.44
+85.72%
16.39
+284.82%
-8.87
+72.99%
-32.83
Normalized Income
30.44
+68.82%
18.03
+303.32%
-8.87
+72.99%
-32.83
Net Income Common Stockholders
30.44
+85.72%
16.39
+284.82%
-8.87
+72.99%
-32.83
Otherunder Preferred Stock Dividend
—
—
—
0.00
Diluted EPS
0.09
+125.00%
0.04
+300.00%
-0.02
+75.00%
-0.08
Basic EPS
0.09
+125.00%
0.04
+300.00%
-0.02
+75.00%
-0.08
Basic Average Shares
356.33
-7.62%
385.74
-5.99%
410.31
-0.62%
412.86
Diluted Average Shares
356.97
-8.98%
392.17
-4.42%
410.31
-0.62%
412.86
Diluted NI Availto Com Stockholders
30.44
+85.72%
16.39
+284.82%
-8.87
+72.99%
-32.83
Average Dilution Earnings
—
—
—
—
Depreciation Amortization Depletion Income Statement
85.22
+22.55%
69.54
-35.41%
107.67
+98.73%
54.18
Depreciation And Amortization In Income Statement
85.22
+22.55%
69.54
-35.41%
107.67
+98.73%
54.18
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
1,404.06
+1.15%
1,388.07
-12.63%
1,588.80
-0.99%
1,604.63
Current Assets
643.10
-2.45%
659.25
-24.47%
872.79
-5.10%
919.69
Cash Cash Equivalents And Short Term Investments
261.82
-41.60%
448.35
-33.31%
672.30
-11.21%
757.16
Cash And Cash Equivalents
261.82
-41.60%
448.35
-33.31%
672.30
-11.21%
757.16
Receivables
254.87
+58.47%
160.83
+0.49%
160.04
+31.55%
121.67
Accounts Receivable
235.75
+61.54%
145.93
+1.62%
143.61
+22.59%
117.14
Other Receivables
11.90
-20.13%
14.90
+15.50%
12.90
—
Taxes Receivable
7.22
0.00
-100.00%
3.54
-21.82%
4.52
Prepaid Assets
—
—
0.00
-100.00%
5.75
Restricted Cash
—
—
—
—
Other Current Assets
126.41
+152.45%
50.08
+23.80%
40.45
+15.22%
35.10
Total Non Current Assets
760.96
+4.41%
728.81
+1.79%
716.01
+4.54%
684.95
Net PPE
41.08
+1.53%
40.46
-11.78%
45.86
-17.70%
55.73
Gross PPE
63.37
+7.97%
58.69
-1.61%
59.65
-8.93%
65.50
Accumulated Depreciation
-22.29
-22.27%
-18.23
-32.24%
-13.79
-41.12%
-9.77
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
15.13
+4.95%
14.42
+6.39%
13.55
+0.41%
13.49
Construction In Progress
3.32
+976.62%
0.31
+82.25%
0.17
0.00
Other Properties
28.81
+3.65%
27.79
-7.13%
29.93
-16.65%
35.91
Leases
16.11
-0.36%
16.17
+1.07%
16.00
-0.60%
16.09
Goodwill And Other Intangible Assets
633.67
+7.83%
587.65
+3.62%
567.11
-5.80%
602.05
Goodwill
430.33
+4.76%
410.77
+0.00%
410.77
-0.33%
412.12
Other Intangible Assets
203.34
+14.96%
176.88
+13.14%
156.34
-17.69%
189.94
Non Current Deferred Assets
57.11
-26.00%
77.18
+18.25%
65.27
0.00
Non Current Deferred Taxes Assets
57.11
-26.00%
77.18
+18.25%
65.27
0.00
Other Non Current Assets
29.09
+23.70%
23.52
-37.74%
37.77
+39.06%
27.16
Total Liabilities Net Minority Interest
787.80
+18.75%
663.41
-19.77%
826.84
+4.69%
789.80
Current Liabilities
246.00
+98.54%
123.90
+1.10%
122.56
+60.59%
76.32
Payables And Accrued Expenses
99.41
+8.72%
91.43
-9.01%
100.49
+75.24%
57.34
Payables
19.41
+24.44%
15.59
-57.00%
36.27
+104.89%
17.70
Accounts Payable
19.41
+37.26%
14.14
-61.02%
36.27
+104.89%
17.70
Current Accrued Expenses
80.00
+5.49%
75.84
+18.09%
64.22
+62.00%
39.64
Pensionand Other Post Retirement Benefit Plans Current
—
—
30.40
+47.28%
20.64
Total Tax Payable
0.00
-100.00%
1.46
0.00
—
Income Tax Payable
0.00
-100.00%
1.46
0.00
—
Current Debt And Capital Lease Obligation
9.75
-8.30%
10.64
-28.92%
14.96
+34.85%
11.10
Current Debt
5.00
+0.00%
5.00
-43.10%
8.79
+25.01%
7.03
Other Current Borrowings
5.00
+0.00%
5.00
-43.10%
8.79
+25.01%
7.03
Current Capital Lease Obligation
4.75
-15.67%
5.64
-8.76%
6.18
+51.84%
4.07
Current Deferred Liabilities
6.71
+11.08%
6.04
-15.05%
7.11
-9.82%
7.88
Current Deferred Revenue
6.71
+11.08%
6.04
-15.05%
7.11
-9.82%
7.88
Other Current Liabilities
130.14
+723.77%
15.80
—
—
Total Non Current Liabilities Net Minority Interest
541.79
+0.42%
539.51
-23.40%
704.28
-1.29%
713.48
Long Term Debt And Capital Lease Obligation
533.05
+0.06%
532.75
-23.47%
696.11
-1.39%
705.93
Long Term Debt
483.26
-0.71%
486.71
-24.86%
647.70
-0.63%
651.80
Long Term Capital Lease Obligation
49.79
+8.14%
46.04
-4.88%
48.40
-10.58%
54.13
Non Current Deferred Liabilities
—
—
—
—
Non Current Deferred Taxes Liabilities
—
—
—
—
Other Non Current Liabilities
8.74
+29.40%
6.75
-17.39%
8.18
+8.20%
7.56
Stockholders Equity
616.26
-14.96%
724.66
-4.90%
761.96
-6.49%
814.83
Common Stock Equity
616.26
-14.96%
724.66
-4.90%
761.96
-6.49%
814.83
Capital Stock
0.03
-10.53%
0.04
-5.00%
0.04
+0.00%
0.04
Common Stock
0.03
-10.53%
0.04
-5.00%
0.04
+0.00%
0.04
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
341.05
-10.91%
382.81
-2.86%
394.09
-0.74%
397.02
Ordinary Shares Number
341.05
-10.91%
382.81
-2.86%
394.09
-0.74%
397.02
Additional Paid In Capital
2,026.80
-6.41%
2,165.63
-2.42%
2,219.32
-1.94%
2,263.32
Retained Earnings
-1,410.57
+2.11%
-1,441.01
+1.12%
-1,457.40
-0.61%
-1,448.54
Total Equity Gross Minority Interest
616.26
-14.96%
724.66
-4.90%
761.96
-6.49%
814.83
Total Capitalization
1,099.53
-9.23%
1,211.37
-14.07%
1,409.66
-3.88%
1,466.62
Working Capital
397.10
-25.82%
535.35
-28.64%
750.23
-11.04%
843.37
Invested Capital
1,104.53
-9.19%
1,216.37
-14.25%
1,418.45
-3.75%
1,473.65
Total Debt
542.81
-0.11%
543.39
-23.58%
711.07
-0.83%
717.02
Net Debt
226.44
+422.18%
43.37
—
—
Capital Lease Obligations
54.54
+5.55%
51.68
-5.32%
54.58
-6.22%
58.20
Net Tangible Assets
-17.41
-112.71%
137.01
-29.69%
194.85
-8.42%
212.77
Tangible Book Value
-17.41
-112.71%
137.01
-29.69%
194.85
-8.42%
212.77
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
167.90
-8.69%
183.89
+32.97%
138.29
-5.78%
146.78
Cash Flow From Continuing Operating Activities
167.90
-8.69%
183.89
+32.97%
138.29
-5.78%
146.78
Net Income From Continuing Operations
30.44
+85.72%
16.39
+284.82%
-8.87
+72.99%
-32.83
Depreciation Amortization Depletion
85.22
+22.55%
69.54
-35.41%
107.67
+98.73%
54.18
Depreciation
—
—
4.80
—
Amortization Cash Flow
—
—
102.90
—
Depreciation And Amortization
85.22
+22.55%
69.54
-35.41%
107.67
+98.73%
54.18
Amortization Of Intangibles
—
—
102.90
—
Other Non Cash Items
7.58
+13.53%
6.68
-47.98%
12.84
-48.26%
24.82
Stock Based Compensation
76.63
-22.62%
99.03
-5.53%
104.82
-12.82%
120.23
Deferred Tax
20.07
+268.47%
-11.91
+81.83%
-65.56
-13091.55%
-0.50
Deferred Income Tax
20.07
+268.47%
-11.91
+81.83%
-65.56
-13091.55%
-0.50
Operating Gains Losses
4.41
+112.28%
2.08
-77.73%
9.33
+700.69%
1.17
Gain Loss On Sale Of PPE
4.41
0.00
-100.00%
9.33
0.00
Change In Working Capital
-56.44
-2795.51%
2.09
+109.55%
-21.94
-8.11%
-20.29
Change In Receivables
-88.02
-3684.01%
-2.33
+91.21%
-26.47
-2024.87%
1.38
Changes In Account Receivables
-88.02
-3684.01%
-2.33
+91.21%
-26.47
-2024.87%
1.38
Change In Prepaid Assets
-8.39
-160.82%
13.79
+182.67%
-16.68
-22.26%
-13.64
Change In Payables And Accrued Expense
5.29
+189.51%
-5.91
-117.75%
33.29
+641.96%
-6.14
Change In Accrued Expense
1.19
-88.04%
9.91
-53.37%
21.25
+503.44%
-5.27
Change In Payable
4.10
+125.94%
-15.82
-231.45%
12.03
+1476.89%
-0.87
Change In Account Payable
4.10
+125.94%
-15.82
-231.45%
12.03
+1476.89%
-0.87
Change In Other Current Assets
-75.39
-910.14%
-7.46
+51.79%
-15.48
—
Change In Other Current Liabilities
110.06
+2650.76%
4.00
+17.47%
3.41
+281.27%
-1.88
Investing Cash Flow
-119.96
-70.53%
-70.35
-26.15%
-55.77
+73.51%
-210.50
Cash Flow From Continuing Investing Activities
-119.96
-70.53%
-70.35
-26.15%
-55.77
+73.51%
-210.50
Net PPE Purchase And Sale
-3.52
-183.95%
-1.24
-18.89%
-1.04
+73.71%
-3.97
Purchase Of PPE
-3.52
-183.95%
-1.24
-18.89%
-1.04
+73.71%
-3.97
Capital Expenditure
-74.02
-5.22%
-70.35
-26.15%
-55.77
-1.00%
-55.21
Capital Expenditure Reported
-70.50
-2.01%
-69.11
-26.29%
-54.72
-6.78%
-51.25
Net Business Purchase And Sale
-43.44
0.00
0.00
+100.00%
-155.28
Purchase Of Business
-43.44
0.00
0.00
+100.00%
-171.86
Gain Loss On Sale Of Business
—
0.00
0.00
+100.00%
-11.40
Net Other Investing Changes
-2.50
—
—
—
Financing Cash Flow
-234.47
+30.53%
-337.50
-101.62%
-167.40
-39.23%
-120.23
Cash Flow From Continuing Financing Activities
-234.47
+30.53%
-337.50
-101.62%
-167.40
-39.23%
-120.23
Net Issuance Payments Of Debt
-5.00
+97.01%
-167.00
-3068.37%
-5.27
+25.01%
-7.03
Issuance Of Debt
0.00
-100.00%
472.03
0.00
0.00
Repayment Of Debt
-5.00
+99.22%
-639.04
-12023.66%
-5.27
+25.01%
-7.03
Long Term Debt Issuance
0.00
-100.00%
472.03
0.00
0.00
Long Term Debt Payments
-5.00
+99.22%
-639.04
-12023.66%
-5.27
+25.01%
-7.03
Net Long Term Debt Issuance
-5.00
+97.01%
-167.00
-3068.37%
-5.27
+25.01%
-7.03
Net Common Stock Issuance
-216.37
-36.22%
-158.84
-52.77%
-103.97
-2.21%
-101.72
Common Stock Payments
-216.37
-36.22%
-158.84
-52.77%
-103.97
-2.21%
-101.72
Repurchase Of Capital Stock
-216.37
-36.22%
-158.84
-52.77%
-103.97
-2.21%
-101.72
Proceeds From Stock Option Exercised
1.37
-93.42%
20.81
+183.89%
7.33
-19.96%
9.16
Net Other Financing Charges
-14.47
+55.43%
-32.46
+50.43%
-65.48
-217.33%
-20.64
Changes In Cash
-186.53
+16.71%
-223.95
-163.88%
-84.87
+53.86%
-183.94
Beginning Cash Position
448.35
-33.31%
672.30
-11.21%
757.16
-19.55%
941.11
End Cash Position
261.82
-41.60%
448.35
-33.31%
672.30
-11.21%
757.16
Free Cash Flow
93.88
-17.32%
113.55
+37.59%
82.53
-9.87%
91.57
Interest Paid Supplemental Data
40.84
-25.88%
55.10
+12.91%
48.80
+58.94%
30.70
Income Tax Paid Supplemental Data
13.13
-44.43%
23.62
+37.00%
17.24
+295.84%
4.36
Common Stock Issuance
—
—
—
0.00
Earnings Losses From Equity Investments
—
—
4.01
0.00
Issuance Of Capital Stock
—
—
—
0.00
Sale Of Business
—
0.00
0.00
-100.00%
16.58
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category